CIM for MedVista Technologies is ready for review. I've generated 8 sections totaling ~12,400 words with formatted financial tables and industry analysis.

Key highlights in this draft:
• Revenue CAGR of 12.2% (FY22-FY26E)
• EBITDA margin expansion from 15.0% to 21.6%
• 180+ hospital installations, 96% retention rate
• $8.8B SAM with 5% current penetration

Click any section on the left to navigate, or ask me to refine specific areas.